This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
After steadily raising its payout by 163% over the past 15 years, (NYSE: PFE) continues to be one of the most reliable pharma stocks an income-seeking investor can reach for these days. The company is a pharmaceutical giant with many parts moving in different directions. Some of its blockbusters are losing market exclusivity, but it's also developing plenty of new drugs to take their place.
Despite a productive development pipeline and a remarkable track record, shares of Pfizer offer a great big 6% dividend yield at recent prices. Here's why it's a great stock for income-seeking investors to buy now and hold for the long run.
At a glance, Pfizer's first-quarter results look awful. Revenue sank by 19% year over year at constant-currency rates. Such a big drop looks like a red flag but it's not as bad as it seems.
Source Fool.com
Pfizer Inc. Stock
The stock is one of the favorites of our community with 28 Buy predictions and 4 Sell predictions.
As a result the target price of 40 € shows a very positive potential of 51.54% compared to the current price of 26.4 € for Pfizer Inc..
